Astrazeneca PLC News Headlines

AZN 
$70.19
*  
0.63
0.91%
Get AZN Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading AZN now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    AZN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
European Shares Slightly Up as Drug Makers Led by AstraZeneca Climb on Pfizer Takeover Talks
8/29/2014 6:48:40 AM - MT Newswires


With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune
8/26/2014 7:18:00 PM - Seeking Alpha


Roche Furthers Immunotherapy Program with SP142 Launch - Analyst Blog
8/26/2014 5:22:00 PM - Zacks.com


Roche to Boost Respiratory Product Lineup with InterMune Buy - Analyst Blog
8/25/2014 2:03:00 PM - Zacks.com


Competition And Momentum Weighing On Clovis Oncology
8/23/2014 7:15:00 AM - Seeking Alpha


AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog
8/22/2014 4:00:00 PM - Zacks.com


Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog
8/22/2014 3:50:00 PM - Zacks.com


3 Reasons Bristol-Myers Squibb's Stock Could Rise
8/22/2014 3:47:28 PM - Motley Fool


Ampio Shares Fall as STEP Study on Ampion Gets Delayed - Analyst Blog
8/22/2014 3:35:00 PM - Zacks.com


Tracking Dan Loeb's Third Point Portfolio - Q2 2014 Update
8/22/2014 4:44:00 AM - Seeking Alpha


GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog
8/21/2014 4:05:00 PM - Zacks.com


Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog
8/21/2014 3:30:00 PM - Zacks.com


Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS - Analyst Blog
8/21/2014 2:30:00 PM - Zacks.com


Nektar Therapeutics Has More To Give
8/21/2014 1:45:00 PM - Seeking Alpha


European ADRs Up as Pharma Companies, Select Banks Gain
8/21/2014 10:16:40 AM - MT Newswires


Sanofi's (SNY) Cerdelga FDA Approved for Gaucher Disease - Analyst Blog
8/20/2014 5:30:00 PM - Zacks.com


Ampio's Ampion Positive in Open Label Study, Shares Up - Analyst Blog
8/20/2014 4:33:00 PM - Zacks.com


Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
8/20/2014 2:53:00 PM - Zacks.com


Why Investing In U.S. Multinationals Is Not The Same As Investing In Foreign Companies
8/20/2014 2:50:00 PM - Seeking Alpha


Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
8/19/2014 4:55:00 PM - Zacks.com


Novo Nordisk to Pay Fine, Tresiba in Focus - Analyst Blog
8/19/2014 4:50:00 PM - Zacks.com


Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
8/19/2014 3:20:00 PM - Zacks.com


Eli Lilly-Boehringer's Insulin Drug Gets Tentative FDA Nod - Analyst Blog
8/19/2014 12:10:00 PM - Zacks.com


Sector Update: Health-Care Shares Higher Pre-Market
8/19/2014 7:30:47 AM - MT Newswires


Sector Update: Health Care
8/19/2014 7:26:09 AM - MT Newswires